Patents by Inventor Jin-Ding HUANG

Jin-Ding HUANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZED AFGF COMPOSITIONS
    Publication number: 20220152153
    Abstract: A stabilized aFGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aFGF, a citric acid compound and other excipients. The method for improving stability of aFGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.
    Type: Application
    Filed: November 15, 2021
    Publication date: May 19, 2022
    Applicant: EUSOL BIOTECH CO., LTD.
    Inventor: Jin-Ding HUANG
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20220071987
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: September 22, 2021
    Publication date: March 10, 2022
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
    Patent number: 11241424
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: February 8, 2022
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
  • Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
    Patent number: 11234974
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: February 1, 2022
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien
  • Use of recombinant protein for treating metabolic disorders
    Patent number: 10946062
    Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: March 16, 2021
    Assignee: EUSOL BIOTECH CO., LTD.
    Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
  • USE OF RECOMBINANT PROTEIN FOR TREATING METABOLIC DISORDERS
    Publication number: 20200276264
    Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.
    Type: Application
    Filed: February 26, 2020
    Publication date: September 3, 2020
    Applicant: Eusol Biotech Co., Ltd.
    Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20200179373
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 11, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20200179372
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: December 30, 2019
    Publication date: June 11, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20200030318
    Abstract: The present invention relates to kits and prefilled syringes comprising pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as methods of treating pain using such formulations.
    Type: Application
    Filed: September 30, 2019
    Publication date: January 30, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20190160053
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: November 19, 2018
    Publication date: May 30, 2019
    Inventors: Chan-Jung LI, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
  • Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
    Patent number: 10183018
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: January 22, 2019
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien
  • PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
    Publication number: 20160346275
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr. TSAI, Shu-Wen KUO, Yu-En TIEN